Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 31 | 2025 | 709 | 4.880 |
Why?
|
| Genetic Vectors | 27 | 2025 | 879 | 4.000 |
Why?
|
| Genetic Therapy | 17 | 2025 | 791 | 1.790 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 5 | 2017 | 142 | 1.260 |
Why?
|
| Capsid | 4 | 2025 | 95 | 1.250 |
Why?
|
| Transduction, Genetic | 7 | 2024 | 238 | 1.250 |
Why?
|
| Osteoblasts | 6 | 2019 | 198 | 1.110 |
Why?
|
| Transgenes | 7 | 2025 | 187 | 0.990 |
Why?
|
| Codon | 1 | 2025 | 56 | 0.900 |
Why?
|
| Retina | 1 | 2024 | 124 | 0.830 |
Why?
|
| Nanopores | 1 | 2022 | 12 | 0.790 |
Why?
|
| Cell Differentiation | 4 | 2017 | 1353 | 0.780 |
Why?
|
| Protein Biosynthesis | 1 | 2025 | 319 | 0.770 |
Why?
|
| Gene Expression | 4 | 2019 | 840 | 0.760 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 385 | 0.710 |
Why?
|
| Gene Transfer Techniques | 9 | 2025 | 321 | 0.700 |
Why?
|
| Animals | 34 | 2025 | 20660 | 0.640 |
Why?
|
| Osteogenesis | 3 | 2017 | 143 | 0.620 |
Why?
|
| Mice | 25 | 2025 | 10844 | 0.620 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 78 | 0.590 |
Why?
|
| Genome, Viral | 5 | 2024 | 136 | 0.590 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 103 | 0.590 |
Why?
|
| Promoter Regions, Genetic | 7 | 2024 | 676 | 0.580 |
Why?
|
| Genome | 2 | 2017 | 276 | 0.560 |
Why?
|
| CCCTC-Binding Factor | 1 | 2017 | 39 | 0.560 |
Why?
|
| Deoxyribonucleases | 1 | 2017 | 32 | 0.550 |
Why?
|
| Gene Expression Regulation | 3 | 2025 | 1617 | 0.490 |
Why?
|
| Liver | 4 | 2025 | 855 | 0.490 |
Why?
|
| MicroRNAs | 4 | 2025 | 687 | 0.450 |
Why?
|
| Genes, Reporter | 4 | 2019 | 257 | 0.450 |
Why?
|
| Eukaryota | 1 | 2014 | 29 | 0.430 |
Why?
|
| Capsid Proteins | 3 | 2025 | 101 | 0.420 |
Why?
|
| Cell Line | 8 | 2019 | 2040 | 0.390 |
Why?
|
| Organ Specificity | 2 | 2025 | 195 | 0.370 |
Why?
|
| beta-Galactosidase | 1 | 2012 | 77 | 0.370 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 93 | 0.350 |
Why?
|
| Genomics | 1 | 2014 | 370 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 3396 | 0.340 |
Why?
|
| Humans | 30 | 2025 | 63461 | 0.330 |
Why?
|
| Genetic Engineering | 3 | 2019 | 117 | 0.310 |
Why?
|
| HEK293 Cells | 4 | 2025 | 622 | 0.270 |
Why?
|
| Gene Editing | 3 | 2021 | 321 | 0.260 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 190 | 0.260 |
Why?
|
| Gene Silencing | 2 | 2019 | 400 | 0.260 |
Why?
|
| DNA, Circular | 1 | 2025 | 7 | 0.240 |
Why?
|
| Liver Failure, Acute | 1 | 2025 | 24 | 0.240 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2025 | 53 | 0.230 |
Why?
|
| Acetaminophen | 1 | 2025 | 58 | 0.230 |
Why?
|
| Plasmids | 2 | 2023 | 292 | 0.220 |
Why?
|
| Carcinogenesis | 2 | 2023 | 130 | 0.220 |
Why?
|
| Recombinational DNA Repair | 2 | 2021 | 25 | 0.220 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 1277 | 0.220 |
Why?
|
| Brain | 2 | 2025 | 1556 | 0.210 |
Why?
|
| Recombination, Genetic | 1 | 2025 | 246 | 0.210 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2024 | 20 | 0.210 |
Why?
|
| Hepatocytes | 1 | 2025 | 218 | 0.210 |
Why?
|
| Central Nervous System | 3 | 2020 | 197 | 0.200 |
Why?
|
| Terminal Repeat Sequences | 1 | 2022 | 13 | 0.200 |
Why?
|
| Recombinant Proteins | 1 | 2025 | 702 | 0.200 |
Why?
|
| Gene Order | 2 | 2019 | 32 | 0.190 |
Why?
|
| Baculoviridae | 1 | 2022 | 25 | 0.190 |
Why?
|
| Insecta | 1 | 2022 | 37 | 0.190 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 10 | 0.180 |
Why?
|
| Tyrosinemias | 1 | 2021 | 20 | 0.180 |
Why?
|
| Transfection | 3 | 2025 | 694 | 0.180 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 46 | 0.180 |
Why?
|
| Retinal Vasculitis | 1 | 2021 | 7 | 0.180 |
Why?
|
| Microglia | 1 | 2024 | 242 | 0.180 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 28 | 0.180 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 878 | 0.170 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 313 | 0.170 |
Why?
|
| Lentivirus | 1 | 2021 | 66 | 0.170 |
Why?
|
| Communicable Diseases | 1 | 2021 | 90 | 0.170 |
Why?
|
| DNA, Viral | 2 | 2020 | 232 | 0.160 |
Why?
|
| Cisterna Magna | 1 | 2019 | 15 | 0.160 |
Why?
|
| Algorithms | 1 | 2025 | 1003 | 0.160 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 40 | 0.150 |
Why?
|
| Bone Resorption | 1 | 2019 | 42 | 0.150 |
Why?
|
| Antigen Presentation | 1 | 2021 | 237 | 0.150 |
Why?
|
| Ovalbumin | 1 | 2019 | 116 | 0.150 |
Why?
|
| Immunotherapy | 1 | 2021 | 255 | 0.150 |
Why?
|
| Macular Degeneration | 1 | 2021 | 187 | 0.150 |
Why?
|
| Osteoporosis | 1 | 2019 | 106 | 0.150 |
Why?
|
| Genes, Recessive | 1 | 2018 | 52 | 0.150 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 178 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2019 | 139 | 0.140 |
Why?
|
| Immunity, Innate | 2 | 2021 | 796 | 0.140 |
Why?
|
| Heterozygote | 1 | 2018 | 170 | 0.140 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 24 | 0.140 |
Why?
|
| Neoplasms | 2 | 2021 | 1364 | 0.140 |
Why?
|
| Gene Ontology | 1 | 2017 | 38 | 0.140 |
Why?
|
| Inverted Repeat Sequences | 1 | 2017 | 14 | 0.130 |
Why?
|
| Introns | 1 | 2017 | 111 | 0.130 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 771 | 0.130 |
Why?
|
| Computational Biology | 1 | 2019 | 356 | 0.130 |
Why?
|
| Alleles | 1 | 2018 | 448 | 0.130 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 99 | 0.130 |
Why?
|
| Embryonic Development | 1 | 2018 | 136 | 0.130 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2016 | 5 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2014 | 2157 | 0.130 |
Why?
|
| Alphavirus | 1 | 2015 | 3 | 0.120 |
Why?
|
| Colforsin | 1 | 2015 | 24 | 0.120 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 74 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2017 | 270 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2014 | 1513 | 0.120 |
Why?
|
| Cyclic AMP | 1 | 2015 | 143 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 231 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 740 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 112 | 0.110 |
Why?
|
| Luciferases | 1 | 2014 | 109 | 0.110 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 361 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2014 | 197 | 0.100 |
Why?
|
| Risk Factors | 1 | 2023 | 5354 | 0.100 |
Why?
|
| Metalloproteases | 1 | 2013 | 4 | 0.100 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2013 | 12 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 542 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1186 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 32 | 0.100 |
Why?
|
| Frozen Sections | 1 | 2012 | 10 | 0.090 |
Why?
|
| Base Sequence | 1 | 2014 | 1331 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 2186 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2012 | 126 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 146 | 0.090 |
Why?
|
| Monocytes | 1 | 2013 | 353 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1991 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 642 | 0.080 |
Why?
|
| Serogroup | 2 | 2020 | 35 | 0.080 |
Why?
|
| Mutation | 1 | 2018 | 2609 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 2 | 2021 | 178 | 0.080 |
Why?
|
| Chromatin | 1 | 2014 | 608 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2016 | 3036 | 0.070 |
Why?
|
| Virus Assembly | 2 | 2020 | 53 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 2 | 2019 | 239 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 864 | 0.070 |
Why?
|
| Male | 7 | 2025 | 29900 | 0.070 |
Why?
|
| Ferrets | 1 | 2025 | 12 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2025 | 15 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2025 | 41 | 0.060 |
Why?
|
| Myocardium | 1 | 2007 | 279 | 0.060 |
Why?
|
| Binding Sites | 2 | 2021 | 904 | 0.060 |
Why?
|
| Motor Neurons | 1 | 2024 | 212 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 921 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2017 | 383 | 0.050 |
Why?
|
| Mice, Inbred mdx | 1 | 2021 | 15 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 1469 | 0.050 |
Why?
|
| Dystrophin | 1 | 2021 | 31 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 32 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2022 | 107 | 0.040 |
Why?
|
| Intravitreal Injections | 1 | 2021 | 49 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2021 | 77 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 101 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 376 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2019 | 46 | 0.040 |
Why?
|
| Vaccines | 1 | 2021 | 97 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 213 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 58 | 0.040 |
Why?
|
| Sheep | 1 | 2019 | 179 | 0.040 |
Why?
|
| Catheters | 1 | 2019 | 74 | 0.040 |
Why?
|
| Cartilage | 1 | 2019 | 35 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 135 | 0.040 |
Why?
|
| RNA Stability | 1 | 2019 | 102 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 1650 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 376 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2019 | 114 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 236 | 0.040 |
Why?
|
| Female | 4 | 2021 | 32882 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 174 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 200 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2019 | 181 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 276 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 179 | 0.040 |
Why?
|
| Fallopian Tubes | 1 | 2018 | 11 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2019 | 308 | 0.040 |
Why?
|
| DNA End-Joining Repair | 1 | 2018 | 23 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 268 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 883 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 248 | 0.030 |
Why?
|
| Blastocyst | 1 | 2018 | 72 | 0.030 |
Why?
|
| Endonucleases | 1 | 2018 | 84 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 117 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 760 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2016 | 30 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 367 | 0.030 |
Why?
|
| Response Elements | 1 | 2016 | 44 | 0.030 |
Why?
|
| RNA Interference | 1 | 2019 | 618 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2019 | 525 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2016 | 81 | 0.030 |
Why?
|
| Oncolytic Virotherapy | 1 | 2015 | 6 | 0.030 |
Why?
|
| Oncolytic Viruses | 1 | 2015 | 7 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 517 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2015 | 51 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 415 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 44 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2015 | 60 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 263 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 935 | 0.030 |
Why?
|
| DNA Replication | 1 | 2017 | 235 | 0.030 |
Why?
|
| Synteny | 1 | 2014 | 23 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 678 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 2109 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 481 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 525 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 19 | 0.030 |
Why?
|
| ADAM17 Protein | 1 | 2013 | 8 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 2013 | 30 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 39 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 158 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 339 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 768 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1178 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1644 | 0.020 |
Why?
|
| COS Cells | 1 | 2012 | 175 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 101 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 2337 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2173 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1079 | 0.020 |
Why?
|
| Proteomics | 1 | 2012 | 284 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1603 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 1981 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2007 | 42 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 234 | 0.020 |
Why?
|